What we're reading, December 24, 2015: more than half of Affordable Care Act co-ops will be closed by the end of 2015, but this could have been avoided; 5 senators are pressing CMS for information on containing drug costs; and a task force does not recommend screening all teens and children for high cholesterol.
More than half of the co-ops created by the Affordable Care Act will no longer exist by the end of 2015, but this could have been avoided, according to Modern Healthcare. The co-ops struggled with sick, costly patients who were unfamiliar with health insurance and fewer payments from the federal government than initially promised. However, if Congress had paid out what was promised, the co-ops would not have failed, according to insiders.
Five senators are pressing CMS to provide more information on its efforts to contain prescription drug costs and assist seniors. A letter from the 5 Democrats asks how the agency will improve drug pricing transparency and bring down costs, according to a blog post from the Association of Health Care Journalists. The senators sit on committees that oversee issues related to Medicare, Medicaid, and healthcare costs.
The United States Preventive Services Task Force has determined that there is not enough evidence to recommend screening all children and teens for high cholesterol. The draft recommendation remains unchanged from 2007 as it is unclear if screening before the age of 20 reduces the risk of cardiovascular disease later in life, reported HealthDay. The experts added that potential harms for long-term use of cholesterol-lowering medications is still unknown.
Trump Administration’s Message to Supreme Court Puts New Wrinkle in Braidwood Case
February 21st 2025The Trump administration argues that HHS Secretary Robert F. Kennedy Jr can overrule the US Preventive Services Task Force to determine the preventive services covered under the Affordable Care Act.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury
February 21st 2025Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.
Read More
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More